openPR Logo
Press release

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017 : Bristol-Myers Squibb, Amylin

07-20-2017 03:54 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: QYresearchreports

Market Research Reports

Market Research Reports

Qyresearchreports include new market research report "Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017" to its huge collection of research reports.

Notes:
Production, means the output of Glucagon Like Peptide-1 (GLP-1) Agonists
Revenue, means the sales value of Glucagon Like Peptide-1 (GLP-1) Agonists

This report studies Glucagon Like Peptide-1 (GLP-1) Agonists in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
...

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Glucagon Like Peptide-1 (GLP-1) Agonists in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Enter your information below to receive a sample copy of this report @

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Exenatied
Liraglutide
Lixisenatide
Abliglutide
Dulaglutide

Split by application, this report focuses on consumption, market share and growth rate of Glucagon Like Peptide-1 (GLP-1) Agonists in each application, can be divided into
Hospital
Pharmacy

Browse full table of contents and data tables of Report @

Table of Contents

1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
1.2.1 Global Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2015
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
1.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region
1.5 Global Market Size (Value) of Glucagon Like Peptide-1 (GLP-1) Agonists (2011-2021)

2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Competition by Manufacturers
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Share by Manufacturers (2015 and 2016)
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Sales Area and Product Type
2.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends

Table of Contents

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017
1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
1.2.1 Global Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2015
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Abliglutide
1.2.6 Dulaglutide
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
1.3.1 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Glucagon Like Peptide-1 (GLP-1) Agonists (2011-2021)

2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Competition by Manufacturers
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Share by Manufacturers (2015 and 2016)
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Sales Area and Product Type
2.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
2.5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate
2.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue (Value) by Region (2011-2016)
3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Market Share by Region (2011-2016)
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2011-2016)

7 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Profiles/Analysis
7.1 Novo Nordisk
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
7.1.2.1 Exenatied
7.1.2.2 Liraglutide
7.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 AstraZeneca
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
7.2.2.1 Exenatied
7.2.2.2 Liraglutide
7.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview

List of Tables and Figures

Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2015
Table Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2015
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2011-2021)

QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2017 : Bristol-Myers Squibb, Amylin here

News-ID: 634203 • Views: 125

More Releases from QYresearchreports

Global Oilfield Communication Equipment Market Latest Achievements and Opportuni …
Qyresearchreports include new market research report Global Oilfield Communication Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Oilfield Communication Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to
Global Power Over Ethernet (POE) Lighting Market : Key Growth Factors and Foreca …
Qyresearchreports include new market research report Global Power Over Ethernet (POE) Lighting Market Insights, Forecast to 2025 to its huge collection of research reports. This report presents the worldwide Power Over Ethernet (POE) Lighting market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities
Global Automatic Palletizer and Depalletizer Market to be at Forefront by 2025 | …
Qyresearchreports include new market research report Global Automatic Palletizer and Depalletizer Market Insights, Forecast to 2025 to its huge collection of research reports. Automatic palletizer and depalletizer is a machine that enables automatic stacking of goods and products. It also enables the depalletizing or unloading of goods. The rising consumer income and European Central Bank (ECB) bond-buying program will influence the buying pattern of consumers in EMEA and will result in
Global Weather Forecasting Equipment Market Advancement Analysis and Precise Out …
Qyresearchreports include new market research report Global Weather Forecasting Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Weather Forecasting Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to

All 5 Releases


More Releases for Glucagon

Glucagon Market Latest Technology Innovations, Size, Growth with CAGR of 6.3% by …
Market.us add the Latest report on "Global Glucagon Market By Type (Inject Glucagon, and Nasal Glucagon), By Application (Emergency Kits, General Use, and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028" to its Gigantic Report Online Store. The Global Glucagon Market was valued at US$ 451.2 Mn in 2018 and is projected to increase significantly at a CAGR of 6.3% from
Global Glucagon Market Size Growing at a CAGR of 6.1% during 2018-2025
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Glucagon Market” Research Report 2018 provides an in-depth analysis of the Glucagon Market with the forecast of market size and growth. The analysis includes addressable market, market by volume, and market share by business type and by segment (external and in-house).The research study examines the Glucagon Market on the basis
Glucagon-Like Peptide-1 (Glp-1) Analogs Market : Deep Analysis by Production Ove …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Glucagon-Like Peptide-1 (Glp-1) Analogs Market | Global Opportunity Analysis, 20 …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Glucagon Industry Global Supply & Consumption Analysis Market Report 2017
Qyresearchreports include new market research report Global Glucagon Market Research Report 2017 to its huge collection of research reports. The global market for Glucagon is being molded by different factors and a complete assessment of those have been furnished in the report. The report begins with a brief description of the product and then goes onto study the various growth drivers and restraints in the market. Apart from that, the report
Glucagon Like Peptide 2 Receptor (GLP2R) – Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Glucagon Like Peptide 2 Receptor (GLP2R) – Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height